Healthcare Antitrust, Settlements, and the Federal Trade Commission (Research in Law and Economics)

個数:

Healthcare Antitrust, Settlements, and the Federal Trade Commission (Research in Law and Economics)

  • 提携先の海外書籍取次会社に在庫がございます。通常3週間で発送いたします。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合が若干ございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Hardcover:ハードカバー版/ページ数 488 p.
  • 言語 ENG
  • 商品コード 9781787566002
  • DDC分類 343.730721

Full Description

This volume of Research in Law and Economics contains articles that address important legal and economic developments in the areas of healthcare, intellectual property and labor settlements, competitive effects, cartel overcharges, and the U.S. Federal Trade Commission ("FTC"). Four of the articles were initially presented at a conference on healthcare competition in Washington, D.C., which was sponsored by the American Antitrust Institute, this journal, and Navigant Economics. These articles explore practices that are under challenge in pharmaceuticals, where the Federal Trade Commission has been extremely active, as well as issues involving hospital and health insurance mergers. They are followed by a long and detailed discussion of the current and historic role of economists and economic analysis at the Federal Trade Commission. The next two articles analyze different aspects of the French economy, pre-trial labor settlements and the impact of e-commerce on franchisees. The volume ends with three technical economics articles - one on "upward pricing pressure", one on estimating price increases in cartel cases, and one critiquing a "meta-analysis" of research on the effectiveness of U.S. merger regulation. Taken together, these articles raise questions about appropriate competition policy, how to evaluate settlements and other firm behavior, and where economics and competition policy are headed.

Contents

IntroductionChapter 1. "TO KNOW WHERE YOU'RE GOING, LOOK AT WHERE YOU'VE BEEN"; Deborah L. Feinstein
Chapter 2. ACTAVIS, AUTHORIZED GENERICS, AND THE FUTURE OF ANTITRUST LAW; Marc G. Schildkraut
Chapter 3. SOLVING THE PRODUCT HOPPING CONUNDRUM THROUGH SAFE HARBORS AND A NO-ECONOMIC-SENSE TEST; Michael A. Carrier and Steve D. Shadowen
Chapter 4. A MARKET ALL ITS OWN: MEDICARE ADVANTAGE AS A SEPARATE PRODUCT MARKET IN THE DOJ'S CASE AGAINST THE AETNA-HUMANA MERGER; Douglas Ross and David Maas
Chapter 5. A HISTORY OF THE FTC'S BUREAU OF ECONOMICS; Paul A. Pautler
Chapter 6. LABOR DISPUTES AND PRETRIAL SETTLEMENTS: THE FRENCH CASE; Jean-Christian Tisserand
Chapter 7. FRANCHISEES FACING ONLINE SALES IN A EUROPEAN LEGAL CONTEXT; Guy Basset, Rozenn Perrigot, and Gerard Cliquet
Chapter 8. MANDATORY UPSTREAM INPUTS AND UPWARD PRICING PRESSURE: IMPLICATIONS FOR COMPETITION POLICY; Timothy J. Tardiff and Dennis L. Weisman
Chapter 9. WHEN IS THE "KENNEDY CORRECTION" APPROPRIATE IN ESTIMATING OVERCHARGES?; Wenqing Li and James F. Nieberding
Chapter 10. KWOKA'S MERGERS, MERGER CONTROL, AND REMEDIES: REJOINDER TO KWOKA; Michael Vita

最近チェックした商品